BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 36355973)

  • 1. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
    Offor BC; Muller B; Piater LA
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom.
    Whiteley G; Casewell NR; Pla D; Quesada-Bernat S; Logan RAE; Bolton FMS; Wagstaff SC; Gutiérrez JM; Calvete JJ; Harrison RA
    J Proteomics; 2019 Apr; 198():186-198. PubMed ID: 30290233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical threat of mamba envenoming in sub-Saharan Africa revealed by genus-wide analysis of venom composition, toxicity and antivenomics profiling of available antivenoms.
    Ainsworth S; Petras D; Engmark M; Süssmuth RD; Whiteley G; Albulescu LO; Kazandjian TD; Wagstaff SC; Rowley P; Wüster W; Dorrestein PC; Arias AS; Gutiérrez JM; Harrison RA; Casewell NR; Calvete JJ
    J Proteomics; 2018 Feb; 172():173-189. PubMed ID: 28843532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative characterization of the venom of the coral snake Micrurus dumerilii (Elapidae) from Colombia: Proteome, toxicity, and cross-neutralization by antivenom.
    Rey-Suárez P; Núñez V; Fernández J; Lomonte B
    J Proteomics; 2016 Mar; 136():262-73. PubMed ID: 26883873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venomous snakes of Costa Rica: biological and medical implications of their venom proteomic profiles analyzed through the strategy of snake venomics.
    Lomonte B; Fernández J; Sanz L; Angulo Y; Sasa M; Gutiérrez JM; Calvete JJ
    J Proteomics; 2014 Jun; 105():323-39. PubMed ID: 24576642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative venomics and preclinical efficacy evaluation of a monospecific Hemachatus antivenom towards sub-Saharan Africa cobra venoms.
    Sánchez A; Segura Á; Pla D; Munuera J; Villalta M; Quesada-Bernat S; Chavarría D; Herrera M; Gutiérrez JM; León G; Calvete JJ; Vargas M
    J Proteomics; 2021 May; 240():104196. PubMed ID: 33775842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic characteristics of six snake venoms from the Viperidae and Elapidae families in China and their relation to local tissue necrosis.
    Qin WG; Zhuo ZP; Hu H; Lay M; Li QQ; Huang JT; Zeng LB; Liang ZJ; Long F; Liang Q
    Toxicon; 2023 Nov; 235():107317. PubMed ID: 37839739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
    Alomran N; Alsolaiss J; Albulescu LO; Crittenden E; Harrison RA; Ainsworth S; Casewell NR
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009659. PubMed ID: 34407084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic characterization of six Taiwanese snake venoms: Identification of species-specific proteins and development of a SISCAPA-MRM assay for cobra venom factors.
    Liu CC; Lin CC; Hsiao YC; Wang PJ; Yu JS
    J Proteomics; 2018 Sep; 187():59-68. PubMed ID: 29929037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compendium of medically important snakes, venom activity and clinical presentations in Ghana.
    Deikumah JP; Biney RP; Awoonor-Williams JK; Gyakobo MK
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011050. PubMed ID: 37506181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the phylogeographic distribution of the 3FTx/PLA
    Sanz L; Quesada-Bernat S; Ramos T; Casais-E-Silva LL; Corrêa-Netto C; Silva-Haad JJ; Sasa M; Lomonte B; Calvete JJ
    J Proteomics; 2019 May; 200():90-101. PubMed ID: 30946991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
    Alomran N; Blundell P; Alsolaiss J; Crittenden E; Ainsworth S; Dawson CA; Edge RJ; Hall SR; Harrison RA; Wilkinson MC; Menzies SK; Casewell NR
    Toxins (Basel); 2022 Jun; 14(7):. PubMed ID: 35878181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivenom Neutralization of Coagulopathic Snake Venom Toxins Assessed by Bioactivity Profiling Using Nanofractionation Analytics.
    Xie C; Slagboom J; Albulescu LO; Bruyneel B; Still KBM; Vonk FJ; Somsen GW; Casewell NR; Kool J
    Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31963329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics and antivenomics of Papuan black snake (Pseudechis papuanus) venom with analysis of its toxicological profile and the preclinical efficacy of Australian antivenoms.
    Pla D; Bande BW; Welton RE; Paiva OK; Sanz L; Segura Á; Wright CE; Calvete JJ; Gutiérrez JM; Williams DJ
    J Proteomics; 2017 Jan; 150():201-215. PubMed ID: 27650695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy.
    Gopal G; Muralidar S; Prakash D; Kamalakkannan A; Indhuprakash ST; Thirumalai D; Ambi SV
    Int J Biol Macromol; 2023 Jul; 242(Pt 1):124771. PubMed ID: 37169043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling the Murine Acute Phase and Inflammatory Responses to African Snake Venom: An Approach to Inform Acute Snakebite Pathology.
    Alsolaiss J; Evans CA; Oluoch GO; Casewell NR; Harrison RA
    Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca.
    Lauridsen LP; Laustsen AH; Lomonte B; Gutiérrez JM
    J Proteomics; 2017 Jan; 150():98-108. PubMed ID: 27593527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
    Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
    Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Insights into the Venom Composition of Two Ecuadorian Coral Snakes.
    Hernández-Altamirano JA; Salazar-Valenzuela D; Medina-Villamizar EJ; Quirola DR; Patel K; Vaiyapuri S; Lomonte B; Almeida JR
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.